PLRX Q3 2021 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$82M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-66.6% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$27M-1684.0% margin

Net Income

-$27M-1679.8% margin

EPS (Diluted)

$-0.75

QoQ Revenue Growth

-10.0%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$234M

Total Liabilities

$14M

Stockholders' Equity

$220M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$5M	-66.6%
Gross Profit	$2M	$5M	-66.6%
Operating Income	-$27M	-$17M	-62.7%
Net Income	-$27M	-$17M	-63.6%